KRT17
Basic information
Region (hg38): 17:41619442-41624842
Previous symbols: [ "PCHC1" ]
Links
Phenotypes
GenCC
Source:
- pachyonychia congenita 2 (Strong), mode of inheritance: AD
- sebocystomatosis (Strong), mode of inheritance: AD
- sebocystomatosis (Strong), mode of inheritance: AD
- pachyonychia congenita 2 (Strong), mode of inheritance: AD
- pachyonychia congenita (Supportive), mode of inheritance: AD
- sebocystomatosis (Supportive), mode of inheritance: AD
- sebocystomatosis (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Steatocystoma multiplex; Pachyonychia congenita 2 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dental; Dermatologic | 7529318; 7539673; 9008238; 11886499; 20301457; 22264670 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (5 variants)
- Pachyonychia congenita 2 (4 variants)
- Pachyonychia congenita 2;Steatocystoma multiplex (1 variants)
- Abnormality of the skin (1 variants)
- Anonychia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KRT17 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 10 | 24 | |||
missense | 32 | 13 | 59 | |||
nonsense | 2 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 5 | 5 | 11 | ||
non coding | 9 | |||||
Total | 5 | 2 | 34 | 32 | 23 |
Highest pathogenic variant AF is 0.0000131
Variants in KRT17
This is a list of pathogenic ClinVar variants found in the KRT17 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-41619618-C-T | Benign (Jan 29, 2024) | |||
17-41619619-T-C | Uncertain significance (Jun 23, 2023) | |||
17-41619622-C-A | Benign (Sep 27, 2022) | |||
17-41619622-C-T | Likely benign (Nov 19, 2022) | |||
17-41619623-G-A | Likely benign (Dec 21, 2023) | |||
17-41619654-T-C | Likely benign (Dec 31, 2019) | |||
17-41619667-C-A | Uncertain significance (Nov 10, 2023) | |||
17-41619677-G-A | Uncertain significance (Dec 27, 2022) | |||
17-41619706-AA-GC | Likely benign (Jan 16, 2024) | |||
17-41620536-G-A | Likely benign (Aug 17, 2023) | |||
17-41620547-T-C | Inborn genetic diseases | Uncertain significance (Dec 13, 2022) | ||
17-41620558-G-A | Inborn genetic diseases | Likely benign (Mar 07, 2024) | ||
17-41620565-GA-G | Benign (Jan 25, 2024) | |||
17-41620565-G-GA | Benign (Jan 20, 2024) | |||
17-41620565-G-GAA | KRT17-related disorder | Likely benign (May 01, 2019) | ||
17-41620677-A-G | not provided (-) | |||
17-41620683-C-T | Uncertain significance (Jun 19, 2023) | |||
17-41620713-C-T | Likely benign (Jul 27, 2023) | |||
17-41620714-G-A | Likely benign (Mar 26, 2023) | |||
17-41620728-A-G | not provided (-) | |||
17-41620739-G-T | Uncertain significance (Jul 01, 2022) | |||
17-41620779-G-T | Inborn genetic diseases | Uncertain significance (Jun 07, 2023) | ||
17-41620795-C-T | Benign (Dec 23, 2023) | |||
17-41620847-T-C | Likely benign (Jul 07, 2023) | |||
17-41620876-C-T | Likely benign (Oct 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KRT17 | protein_coding | protein_coding | ENST00000311208 | 8 | 5406 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.10e-11 | 0.0884 | 125612 | 0 | 136 | 125748 | 0.000541 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.492 | 283 | 261 | 1.09 | 0.0000187 | 2808 |
Missense in Polyphen | 62 | 67.323 | 0.92093 | 892 | ||
Synonymous | -1.19 | 125 | 109 | 1.14 | 0.00000710 | 877 |
Loss of Function | 0.401 | 18 | 19.9 | 0.903 | 0.00000106 | 220 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00125 | 0.00125 |
Ashkenazi Jewish | 0.000893 | 0.000893 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000585 | 0.000580 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.000458 | 0.000457 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Type I keratin involved in the formation and maintenance of various skin appendages, specifically in determining shape and orientation of hair (By similarity). Required for the correct growth of hair follicles, in particular for the persistence of the anagen (growth) state (By similarity). Modulates the function of TNF-alpha in the specific context of hair cycling. Regulates protein synthesis and epithelial cell growth through binding to the adapter protein SFN and by stimulating Akt/mTOR pathway (By similarity). Involved in tissue repair. May be a marker of basal cell differentiation in complex epithelia and therefore indicative of a certain type of epithelial "stem cells". Acts as a promoter of epithelial proliferation by acting a regulator of immune response in skin: promotes Th1/Th17-dominated immune environment contributing to the development of basaloid skin tumors (By similarity). May act as an autoantigen in the immunopathogenesis of psoriasis, with certain peptide regions being a major target for autoreactive T-cells and hence causing their proliferation. {ECO:0000250|UniProtKB:Q9QWL7, ECO:0000269|PubMed:10844551, ECO:0000269|PubMed:15795121, ECO:0000269|PubMed:16713453}.;
- Disease
- DISEASE: Pachyonychia congenita 2 (PC2) [MIM:167210]: An autosomal dominant ectodermal dysplasia characterized by hypertrophic nail dystrophy resulting in onchyogryposis (thickening and increase in curvature of the nail), palmoplantar keratoderma and hyperhidrosis, follicular hyperkeratosis, multiple epidermal cysts, absent/sparse eyebrow and body hair, and by the presence of natal teeth. {ECO:0000269|PubMed:10571744, ECO:0000269|PubMed:11348474, ECO:0000269|PubMed:11874497, ECO:0000269|PubMed:11886499, ECO:0000269|PubMed:15102078, ECO:0000269|PubMed:15795125, ECO:0000269|PubMed:16250206, ECO:0000269|PubMed:16620218, ECO:0000269|PubMed:16625196, ECO:0000269|PubMed:17719747, ECO:0000269|PubMed:18547302, ECO:0000269|PubMed:19470054, ECO:0000269|PubMed:21326300, ECO:0000269|PubMed:23278621, ECO:0000269|PubMed:23855588, ECO:0000269|PubMed:7539673, ECO:0000269|PubMed:9008238, ECO:0000269|PubMed:9767294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Steatocystoma multiplex (SM) [MIM:184500]: Disease characterized by round or oval cystic tumors widely distributed on the back, anterior trunk, arms, scrotum, and thighs. {ECO:0000269|PubMed:16620218, ECO:0000269|PubMed:9008238, ECO:0000269|PubMed:9767294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=KRT16 and KRT17 are coexpressed only in pathological situations such as metaplasias and carcinomas of the uterine cervix and in psoriasis vulgaris.;
- Pathway
- Estrogen signaling pathway - Homo sapiens (human);Keratinization;Developmental Biology;EGFR1;Glucocorticoid receptor regulatory network
(Consensus)
Recessive Scores
- pRec
- 0.228
Intolerance Scores
- loftool
- 0.191
- rvis_EVS
- -0.24
- rvis_percentile_EVS
- 36.17
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.397
- ghis
- 0.456
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.931
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Krt17
- Phenotype
- digestive/alimentary phenotype; pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- cytoskeleton organization;signal transduction;epidermis development;hair follicle morphogenesis;keratinization;cornification
- Cellular component
- cytosol;intermediate filament;intermediate filament cytoskeleton;extracellular exosome
- Molecular function
- structural constituent of cytoskeleton;protein binding;MHC class II receptor activity;MHC class II protein binding